竣球控股(01481.HK)擬折讓約11.02%配售最多8000萬股 淨籌8200萬港元
格隆匯6月29日丨竣球控股(01481.HK)公吿,於2022年6月29日,公司與配售代理訂立配售協議,據此,配售代理已有條件及個別的(但非共同及個別的)同意按盡力基準促成承配人以每股配售股份1.05港元配售價認購合共最多8000萬股配售股份。配售價1.05港元較股份於配售協議日期在聯交所所報的收市價每股1.18港元折讓約11.02%;
配售股份佔經配發及發行配售股份(假設公司已發行股本概無其他變動)而擴大公司已發行股本約7.41%。配售股份將根據一般授權予以配發及發行。因此,配售事項毋須股東批准。
假設所有配售股份獲悉數配售,配售事項的所得款項總額及所得款項淨額(扣減相關開支後)將分別約為8400萬港元及8200萬港元,相當於每股配售股份淨髮行價約1.025港元。公司擬將配售事項的所得款項淨額用於藥業相關項目的潛在發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.